RACHAEL MURPHY: Open Payments
NPI 1528039781 · COVINGTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,674 in 89 payments from 26 companies in 2025. Trend: 2023 $1,892 · 2024 $3,106 · 2025 $1,674
Food & beverage: $1,674
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $249 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $154 |
| Supernus Pharmaceuticals, Inc. | 8 | $135 |
| Axsome Therapeutics, Inc. | 6 | $119 |
| Amneal Pharmaceuticals LLC | 5 | $108 |
| Lilly USA, LLC | 6 | $106 |
| Noven Therapeutics, LLC | 5 | $98 |
| TOLMAR, INC. | 4 | $88 |
| Intra-Sana Laboratories | 4 | $83 |
| GlaxoSmithKline, LLC. | 2 | $55 |
Products named: CAPLYTA, Qelbree, Auvelity, UNITHROID, MOUNJARO, Xelstrym, JATENZO, RELTONE 200 MG.
Industry payments across LA — which companies pay providers there.
